Nuzenio

Immunotherapy The Manila

Immunotherapy The Manila entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 17 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Purple Biotech Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 11:21:03 GMTFDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:56:19 GMTHP Inc. to Announce Third Quarter Fiscal 2026 Earnings on August 26, 2026 and to Attend Upcoming Investor Conferences - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:35:57 GMTKULR Technology Group Sets Second Quarter 2026 Earnings Call for Thursday, August 13, 2026 at 4:30 p.m. ET - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:35:37 GMTIN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:50 GMTCreative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 13:27:21 GMTLENSAR® to Report Second Quarter 2026 Results on August 13th, 2026 - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:22:04 GMTCellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for Next-Generation Solid Tumor Immunotherapy - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 00:12:54 GMT

Timeline

Fri, 07 Aug 2026 11:21:03 GMTPurple Biotech Reports Second Quarter 2026 Financial Results - The Manila Times
Thu, 06 Aug 2026 20:56:19 GMTFDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - The Manila Times
Thu, 06 Aug 2026 20:35:57 GMTHP Inc. to Announce Third Quarter Fiscal 2026 Earnings on August 26, 2026 and to Attend Upcoming Investor Conferences - The Manila Times
Thu, 06 Aug 2026 20:35:37 GMTKULR Technology Group Sets Second Quarter 2026 Earnings Call for Thursday, August 13, 2026 at 4:30 p.m. ET - The Manila Times
Thu, 06 Aug 2026 20:13:50 GMTIN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Thu, 06 Aug 2026 13:27:21 GMTCreative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Immunotherapy The Manila.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.